Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2619047 | 1.00 | TACR1 (0.47) | TACR1CYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL11145716 | 0.95 | TACR1 (0.43) | TACR1CYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL15020207 | 0.95 | TACR1 (0.43) | TACR1CYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL15020074 | 0.95 | TACR1 (0.43) | TACR1CYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL1324374 | 0.94 | CA2 (0.43) | TACR1CYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL1323726 | 0.88 | CA2 (0.40) | TACR1CYP1A2RAB9AALDH1A1 | |
| SCHEMBL908789 | 0.88 | CA2 (0.40) | TACR1CYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL28936084 | 0.87 | CYP1A2 (0.54) | TACR1CYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL29503741 | 0.87 | CYP1A2 (0.50) | TACR1CYP1A2ALDH1A1L3MBTL1 | |
| SCHEMBL13609729 | 0.87 | CYP1A2 (0.50) | TACR1CYP1A2ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704174-A1 | SLURRY FOR FORMING ELECTRODE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND METHOD FOR MANUFACTURING SAME, AND DISPERSANT | FUJIFILM Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-20260045499-A1 | SLURRY FOR FORMING ELECTRODE, NON-AQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY AND METHOD FOR MANUFACTURING THE SAME, AND DISPERSANT | FUJIFILM CORPORATION (JP) | 2026-02-12 | — | — | US | disclosed |
| WO-2024225136-A1 | SLURRY FOR FORMING ELECTRODE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND METHOD FOR MANUFACTURING SAME, AND DISPERSANT | 富士フイルム株式会社 | 2024-10-31 | — | — | WO | disclosed |
| EP-4214247-A1 | COMPOSITION COMPRISING ADDITIVE HAVING A POLYCYCLIC AROMATIC GROUP | E Ink Corporation (US) | 2023-07-26 | — | — | EP | disclosed |
| WO-2022060692-A1 | COMPOSITION COMPRISING ADDITIVE HAVING A POLYCYCLIC AROMATIC GROUP | E INK CORPORATION (US) | 2022-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260045499-A1 | SLURRY FOR FORMING ELECTRODE, NON-AQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY AND METHOD FOR MANUFACTURING THE SAME, AND DISPERSANT | DNMT1, DNMT3A, DNMT3B | TACR1 4494/4885CYP1A2 2716/4885SLC1A3 3256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.